Abstract
Background: The impact of COVID-19 on asthmatic patients is still uncertain.
Objective: This study intended to examine the associations between the severity of coronavirus disease 2019 (COVID-19), asthma, and some inflammatory markers among pediatric patients.
Methods: A retrospective study enrolled pediatric COVID-19 patients who were admitted to Abuzar Hospital (Ahvaz, Iran) during eight months. The diagnosis of COVID-19 was according to the real-time reverse transcription-polymerase chain reaction (RT-PCR) method. Asthma diagnosis was confirmed by specialists through functional and clinical evaluations (positive bronchodilator reversibility test or positive methacholine challenge test). Demographic and clinical characteristics of the patients were documented. Asthmatic patients with COVID-19 were considered as Group 1 (n= 52) and non-asthmatic COVID-19 patients were assigned as Group 2 (n= 54).
Results: The mean age of 106 patients was 71.28 ± 50.09 months (range: 1-16 years). Children with severe and moderate COVID-19 had significantly lower levels of neutrophils and lymphocytes, higher inflammatory markers, and longer hospital length of stay (LOS) than patients with a mild course of COVID-19 (p < 0.001). Patients in Group 1 had significantly longer LOS, higher dry cough, chest radiographic findings, fever, levels of D-dimer, fibrinogen, and C-reactive protein (CRP), as well as lower neutrophil and lymphocyte counts, compared with those in Group 2 (p < 0.001).
Conclusion: The presence of asthma in COVID-19 patients was associated with severe COVID-19 in comparison with their non-asthmatic counterparts. Additional studies with large sample sizes are deemed necessary to determine the impact of asthma on the management and incidence of COVID- 19 disease.
Keywords: Asthma, COVID-19, pediatric, CRP, disease severity, Iran.
Graphical Abstract
[1]
Kahn, J.S.; McIntosh, K. History and recent advances in coronavirus discovery. Pediatr. Infect. Dis. J., 2005, 24(11), S223-S227.
[http://dx.doi.org/10.1097/01.inf.0000188166.17324.60] [PMID: 16378050]
[http://dx.doi.org/10.1097/01.inf.0000188166.17324.60] [PMID: 16378050]
[2]
Platto, S.; Xue, T.; Carafoli, E. COVID19: an announced pandemic. Cell Death Dis., 2020, 11(9), 799.
[http://dx.doi.org/10.1038/s41419-020-02995-9] [PMID: 32973152]
[http://dx.doi.org/10.1038/s41419-020-02995-9] [PMID: 32973152]
[3]
Pokorska-Śpiewak M, Talarek E, Popielska J, et al. Comparison of clinical severity and epidemiological spectrum between coronavirus disease 2019 and influenza in children. Sci Rep, 2021, 11(1), 5760.
[http://dx.doi.org/10.1038/s41598-021-85340-0] [PMID: 33707568]
[http://dx.doi.org/10.1038/s41598-021-85340-0] [PMID: 33707568]
[4]
Brough, H.A.; Kalayci, O.; Sediva, A. Managing childhood allergies and immunodeficiencies during respiratory virus epidemics - The 2020 COVID-19 pandemic: A statement from the EAACI-section on pediatrics. Pediatr. Allergy Immunol., 2020, 31(5), 442-448.
[http://dx.doi.org/10.1111/pai.13262] [PMID: 32319129]
[http://dx.doi.org/10.1111/pai.13262] [PMID: 32319129]
[5]
Ferrante, G.; La Grutta, S. The burden of pediatric asthma. Front Pediatr., 2018, 6, 186.
[http://dx.doi.org/10.3389/fped.2018.00186] [PMID: 29988370]
[http://dx.doi.org/10.3389/fped.2018.00186] [PMID: 29988370]
[6]
Kuruvilla, M.E.; Lee, F.E.; Lee, G.B. Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clin. Rev. Allergy Immunol., 2019, 56(2), 219-233.
[http://dx.doi.org/10.1007/s12016-018-8712-1] [PMID: 30206782]
[http://dx.doi.org/10.1007/s12016-018-8712-1] [PMID: 30206782]
[7]
Ricciardolo, F.L.M.; Sprio, A.E.; Baroso, A. Characterization of T2-low and T2-high asthma phenotypes in real-life. Biomedicines, 2021, 9(11), 1684.
[http://dx.doi.org/10.3390/biomedicines9111684] [PMID: 34829913]
[http://dx.doi.org/10.3390/biomedicines9111684] [PMID: 34829913]
[8]
Akar-Ghibril, N.; Casale, T.; Custovic, A.; Phipatanakul, W. Allergic endotypes and phenotypes of asthma. J. Allergy Clin. Immunol. Pract., 2020, 8(2), 429-440.
[http://dx.doi.org/10.1016/j.jaip.2019.11.008] [PMID: 32037107]
[http://dx.doi.org/10.1016/j.jaip.2019.11.008] [PMID: 32037107]
[9]
Trivedi, M.; Denton, E. Asthma in children and adults-what are the differences and what can they tell us about asthma? Front Pediatr., 2019, 7, 256.
[http://dx.doi.org/10.3389/fped.2019.00256] [PMID: 31294006]
[http://dx.doi.org/10.3389/fped.2019.00256] [PMID: 31294006]
[10]
Skevaki, C.; Karsonova, A.; Karaulov, A.; Xie, M.; Renz, H. Asthma-associated risk for COVID-19 development. J. Allergy Clin. Immunol., 2020, 146(6), 1295-1301.
[http://dx.doi.org/10.1016/j.jaci.2020.09.017] [PMID: 33002516]
[http://dx.doi.org/10.1016/j.jaci.2020.09.017] [PMID: 33002516]
[11]
Papadopoulos, N.G.; Custovic, A.; Deschildre, A. Impact of COVID-19 on pediatric burden of asthma: Practice adjustments and disease burden. J. Allergy Clin. Immunol. Pract., 2020, 8(8), 2592-2599.e3.
[http://dx.doi.org/10.1016/j.jaip.2020.06.001] [PMID: 32561497]
[http://dx.doi.org/10.1016/j.jaip.2020.06.001] [PMID: 32561497]
[12]
Jackson, D.J.; Busse, W.W.; Bacharier, L.B. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J. Allergy Clin. Immunol., 2020, 146(1), 203-206.e3.
[http://dx.doi.org/10.1016/j.jaci.2020.04.009] [PMID: 32333915]
[http://dx.doi.org/10.1016/j.jaci.2020.04.009] [PMID: 32333915]
[13]
Schultze, A.; Walker, A.J.; MacKenna, B. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform. Lancet Respir. Med., 2020, 8(11), 1106-1120.
[http://dx.doi.org/10.1016/S2213-2600(20)30415-X] [PMID: 32979987]
[http://dx.doi.org/10.1016/S2213-2600(20)30415-X] [PMID: 32979987]
[14]
Wenzel, S.E. Complex phenotypes in asthma: current definitions. Pulm. Pharmacol. Ther., 2013, 26(6), 710-715.
[http://dx.doi.org/10.1016/j.pupt.2013.07.003] [PMID: 23880027]
[http://dx.doi.org/10.1016/j.pupt.2013.07.003] [PMID: 23880027]
[15]
Larsen, K.; Zhu, J.; Feldman, L.Y. The annual September peak in asthma exacerbation rates. Still a reality? Ann. Am. Thorac. Soc., 2016, 13(2), 231-239.
[PMID: 26636481]
[PMID: 26636481]
[16]
Castro, C.R.; Tarabichi, Y.; Gunzler, D.D.; Ayache, M. Seasonal trends in asthma exacerbations: Are they the same in asthma subgroups? Ann. Allergy Asthma Immunol., 2019, 123(2), 220-222.
[http://dx.doi.org/10.1016/j.anai.2019.05.001] [PMID: 31082480]
[http://dx.doi.org/10.1016/j.anai.2019.05.001] [PMID: 31082480]
[17]
Skevaki, C.; Karsonova, A.; Karaulov, A. SARS-CoV-2 infection and COVID-19 in asthmatics: a complex relationship. Nat. Rev. Immunol., 2021, 21(4), 202-203.
[http://dx.doi.org/10.1038/s41577-021-00516-z] [PMID: 33623123]
[http://dx.doi.org/10.1038/s41577-021-00516-z] [PMID: 33623123]
[18]
Mahdavinia, M.; Foster, K.J.; Jauregui, E. Asthma prolongs intubation in COVID-19. J. Allergy Clin. Immunol. Pract., 2020, 8(7), 2388-2391.
[http://dx.doi.org/10.1016/j.jaip.2020.05.006] [PMID: 32417445]
[http://dx.doi.org/10.1016/j.jaip.2020.05.006] [PMID: 32417445]
[19]
Abe, K.; Miyawaki, A.; Nakamura, M.; Ninomiya, H.; Kobayashi, Y. Trends in hospitalizations for asthma during the COVID-19 outbreak in Japan. J. Allergy Clin. Immunol. Pract., 2021, 9(1), 494-496.e1.
[http://dx.doi.org/10.1016/j.jaip.2020.09.060] [PMID: 33065368]
[http://dx.doi.org/10.1016/j.jaip.2020.09.060] [PMID: 33065368]
[20]
Green, I.; Merzon, E.; Vinker, S.; Golan-Cohen, A.; Magen, E. COVID-19 susceptibility in bronchial asthma. J. Allergy Clin. Immunol. Pract., 2021, 9(2), 684-692.e1.
[http://dx.doi.org/10.1016/j.jaip.2020.11.020] [PMID: 33242628]
[http://dx.doi.org/10.1016/j.jaip.2020.11.020] [PMID: 33242628]
[21]
Jackson, D.J.; Bacharier, L.B. Inhaled corticosteroids for the prevention of asthma exacerbations. Ann. Allergy Asthma Immunol., 2021, 127(5), 524-529.
[http://dx.doi.org/10.1016/j.anai.2021.08.014] [PMID: 34400314]
[http://dx.doi.org/10.1016/j.anai.2021.08.014] [PMID: 34400314]
[22]
Navalpakam, A.; Secord, E.; Pansare, M. The impact of COVID-19 on pediatric asthma in the United States. Pediatr. Clin. North Am., 2021, 68(5), 1119-1131.
[http://dx.doi.org/10.1016/j.pcl.2021.05.012] [PMID: 34538303]
[http://dx.doi.org/10.1016/j.pcl.2021.05.012] [PMID: 34538303]
[23]
Kim, S-H.; Ji, E.; Won, S-H. Association of asthma comorbidity with poor prognosis of coronavirus disease 2019. World Allergy Organ. J., 2021, 14(8), 100576.
[http://dx.doi.org/10.1016/j.waojou.2021.100576] [PMID: 34422204]
[http://dx.doi.org/10.1016/j.waojou.2021.100576] [PMID: 34422204]
[24]
Bailey, L.C.; Razzaghi, H.; Burrows, E.K. Assessment of 135 794 pediatric patients tested for severe acute respiratory syndrome coronavirus 2 across the United States. JAMA Pediatr., 2021, 175(2), 176-184.
[http://dx.doi.org/10.1001/jamapediatrics.2020.5052] [PMID: 33226415]
[http://dx.doi.org/10.1001/jamapediatrics.2020.5052] [PMID: 33226415]
[25]
Secord, E.; Poowuttikul, P.; Pansare, M.; Seth, D.; Saini, S. Pediatric Emergency Visits for Asthma Drop Significantly with COVID19 School Closure. J. Allergy Clin. Immunol., 2021, 147(2), AB150.
[http://dx.doi.org/10.1016/j.jaci.2020.12.541]
[http://dx.doi.org/10.1016/j.jaci.2020.12.541]
[26]
Castro-Rodriguez, J.A.; Forno, E. Asthma and COVID-19 in children: A systematic review and call for data. Pediatr. Pulmonol., 2020, 55(9), 2412-2418.
[http://dx.doi.org/10.1002/ppul.24909] [PMID: 32558360]
[http://dx.doi.org/10.1002/ppul.24909] [PMID: 32558360]
[27]
Sunjaya, A.P.; Allida, S.M.; Di Tanna, G.L.; Jenkins, C. Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: systematic review and meta-analysis. J. Asthma, 2022, 59(5), 866-879.
[PMID: 33556287]
[PMID: 33556287]
[28]
Soeroto, A.Y.; Purwiga, A.; Emmy, H.; Pranggono, E.H.P.; Roesli, R.M.A. Asthma does not increase COVID-19 mortality and poor outcomes: A systematic review and meta-analysis. Asian Pac. J. Allergy Immunol., 2021, 39(2), 63-68.
[PMID: 33865299]
[PMID: 33865299]
[29]
Shaker, M.S.; Oppenheimer, J.; Grayson, M. COVID-19: pandemic contingency planning for the allergy and immunology clinic. J. Allergy Clin. Immunol. Pract., 2020, 8(5), 1477-1488.e5.
[http://dx.doi.org/10.1016/j.jaip.2020.03.012] [PMID: 32224232]
[http://dx.doi.org/10.1016/j.jaip.2020.03.012] [PMID: 32224232]
[30]
Moreno-Sánchez, E.; Castillo-Viera, E.; Vélez-Moreno, E.; Gago-Valiente, F-J. Facts and challenges about asthma and COVID-19 among the paediatric population: A systematic literature review. Medicina, 2021, 57(12), 1306.
[http://dx.doi.org/10.3390/medicina57121306] [PMID: 34946251]
[http://dx.doi.org/10.3390/medicina57121306] [PMID: 34946251]
[31]
Yang, Z.; Wang, X.; Wan, X.G. Pediatric asthma control during the COVID-19 pandemic: A systematic review and meta-analysis. Pediatr. Pulmonol., 2022, 57(1), 20-25.
[http://dx.doi.org/10.1002/ppul.25736] [PMID: 34672436]
[http://dx.doi.org/10.1002/ppul.25736] [PMID: 34672436]
[32]
Shen, K.; Yang, Y.; Wang, T. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement. World J. Clin. Pediatr., 2020, 16(3), 223-231.
[http://dx.doi.org/10.1007/s12519-020-00343-7] [PMID: 32034659]
[http://dx.doi.org/10.1007/s12519-020-00343-7] [PMID: 32034659]
[33]
Dong, Y.; Mo, X.; Hu, Y. Epidemiology of COVID-19 among children in China. Pediatrics, 2020, 145(6), e20200702.
[http://dx.doi.org/10.1542/peds.2020-0702] [PMID: 32179660]
[http://dx.doi.org/10.1542/peds.2020-0702] [PMID: 32179660]
[34]
Fang, F.; Chen, Y.; Zhao, D. Recommendations for the diagnosis, prevention, and control of coronavirus disease-19 in children—the Chinese perspectives. Front Pediatr., 2020, 8, 553394.
[http://dx.doi.org/10.3389/fped.2020.553394] [PMID: 33224906]
[http://dx.doi.org/10.3389/fped.2020.553394] [PMID: 33224906]
[35]
Feketea, G.; Vlacha, V.; Tsiros, G. Vitamin D levels in asymptomatic children and adolescents with atopy during the COVID-19 Era. J. Pers. Med., 2021, 11(8), 712.
[http://dx.doi.org/10.3390/jpm11080712] [PMID: 34442356]
[http://dx.doi.org/10.3390/jpm11080712] [PMID: 34442356]
[36]
Caminati, M.; Vultaggio, A.; Matucci, A. Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity. Respir. Med., 2021, 176, 106261.
[http://dx.doi.org/10.1016/j.rmed.2020.106261] [PMID: 33260107]
[http://dx.doi.org/10.1016/j.rmed.2020.106261] [PMID: 33260107]
[37]
Gaietto, K.; Freeman, M.C.; DiCicco, L.A. Asthma as a risk factor for hospitalization in children with COVID-19: A nested case-control study. Pediatr. Allergy Immunol., 2022, 33(1), e13696.
[http://dx.doi.org/10.1111/pai.13696] [PMID: 34775650]
[http://dx.doi.org/10.1111/pai.13696] [PMID: 34775650]
[38]
Zhang, J.J.; Dong, X.; Cao, Y.Y. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy, 2020, 75(7), 1730-1741.
[http://dx.doi.org/10.1111/all.14238] [PMID: 32077115]
[http://dx.doi.org/10.1111/all.14238] [PMID: 32077115]
[39]
Li, X.; Xu, S.; Yu, M. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J. Allergy Clin. Immunol., 2020, 146(1), 110-118.
[http://dx.doi.org/10.1016/j.jaci.2020.04.006] [PMID: 32294485]
[http://dx.doi.org/10.1016/j.jaci.2020.04.006] [PMID: 32294485]
[40]
Covid, C.; Team, R.; Covid, C.; Team, R. Coronavirus disease 2019 in children-United States, February 12–April 2, 2020. Morb. Mortal. Wkly. Rep., 2020, 69(14), 422-426.
[41]
Parri, N.; Lenge, M.; Buonsenso, D. Children with Covid-19 in pediatric emergency departments in Italy. N. Engl. J. Med., 2020, 383(2), 187-190.
[http://dx.doi.org/10.1056/NEJMc2007617] [PMID: 32356945]
[http://dx.doi.org/10.1056/NEJMc2007617] [PMID: 32356945]
[42]
Zein, J.G.; Erzurum, S.C. Asthma is different in women. Curr. Allergy Asthma Rep., 2015, 15(6), 28.
[http://dx.doi.org/10.1007/s11882-015-0528-y] [PMID: 26141573]
[http://dx.doi.org/10.1007/s11882-015-0528-y] [PMID: 26141573]
[43]
Kynyk, J.A.; Mastronarde, J.G.; McCallister, J.W. Asthma, the sex difference. Curr. Opin. Pulm. Med., 2011, 17(1), 6-11.
[http://dx.doi.org/10.1097/MCP.0b013e3283410038] [PMID: 21045697]
[http://dx.doi.org/10.1097/MCP.0b013e3283410038] [PMID: 21045697]
[44]
Fuseini, H.; Newcomb, D.C. Mechanisms driving gender differences in asthma. Curr. Allergy Asthma Rep., 2017, 17(3), 19.
[http://dx.doi.org/10.1007/s11882-017-0686-1] [PMID: 28332107]
[http://dx.doi.org/10.1007/s11882-017-0686-1] [PMID: 28332107]
[45]
Furci, F.; Caminati, M.; Senna, G.; Gangemi, S. The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID-19. Clin. Mol. Allergy, 2021, 19(1), 19.
[http://dx.doi.org/10.1186/s12948-021-00159-4] [PMID: 34719394]
[http://dx.doi.org/10.1186/s12948-021-00159-4] [PMID: 34719394]
[46]
Robinson, L.B.; Fu, X.; Bassett, I.V. COVID-19 severity in hospitalized patients with asthma: A matched cohort study. J. Allergy Clin. Immunol. Pract., 2021, 9(1), 497-500.
[http://dx.doi.org/10.1016/j.jaip.2020.10.021] [PMID: 33164794]
[http://dx.doi.org/10.1016/j.jaip.2020.10.021] [PMID: 33164794]
[47]
Ruano, F.J.; Alvarez, S.M.L.; Haroun-Díaz, E. Impact of the COVID-19 pandemic in children with allergic asthma. J. Allergy Clin. Immunol. Pract., 2020, 8(9), 3172-3174.e1.
[http://dx.doi.org/10.1016/j.jaip.2020.07.019] [PMID: 32730834]
[http://dx.doi.org/10.1016/j.jaip.2020.07.019] [PMID: 32730834]
[48]
Mendes, N.F.; Jara, C.P.; Mansour, E.; Araújo, E.P.; Velloso, L.A. Asthma and COVID-19: a systematic review. Allergy Asthma Clin. Immunol., 2021, 17(1), 5.
[http://dx.doi.org/10.1186/s13223-020-00509-y] [PMID: 33407838]
[http://dx.doi.org/10.1186/s13223-020-00509-y] [PMID: 33407838]
[49]
Izquierdo, J.L.; Almonacid, C.; González, Y. The impact of COVID-19 on patients with asthma. Eur. Respir. J., 2021, 57(3), 2003142.
[http://dx.doi.org/10.1183/13993003.03142-2020] [PMID: 33154029]
[http://dx.doi.org/10.1183/13993003.03142-2020] [PMID: 33154029]
[50]
Choi, Y.J.; Park, J-Y.; Lee, H.S. Effect of asthma and asthma medication on the prognosis of patients with COVID-19. Eur. Respir. J., 2021, 57(3), 2002226.
[http://dx.doi.org/10.1183/13993003.02226-2020] [PMID: 32978309]
[http://dx.doi.org/10.1183/13993003.02226-2020] [PMID: 32978309]
[51]
Wang, Y.; Chen, J.; Chen, W. Does asthma increase the mortality of patients with COVID-19? a systematic review and meta-analysis. Int. Arch. Allergy Immunol., 2021, 182(1), 76-82.
[http://dx.doi.org/10.1159/000510953] [PMID: 32961539]
[http://dx.doi.org/10.1159/000510953] [PMID: 32961539]
[52]
Metbulut, AP; Mustafaoğlu, Ö; Şen, G Evaluation of the clinical and laboratory findings of asthmatic children with SARS-CoV-2 infection. Int. Arch. Allergy Immunol., 2021, 182(10), 989-996.
[http://dx.doi.org/10.1159/000517153] [PMID: 34167114]
[http://dx.doi.org/10.1159/000517153] [PMID: 34167114]
[53]
Graff, K.; Smith, C.; Silveira, L. Risk factors for severe COVID-19 in children. Pediatr. Infect. Dis. J., 2021, 40(4), e137-e145.
[http://dx.doi.org/10.1097/INF.0000000000003043] [PMID: 33538539]
[http://dx.doi.org/10.1097/INF.0000000000003043] [PMID: 33538539]
[54]
Floyd, G.C.; Dudley, J.W.; Xiao, R. Prevalence of asthma in hospitalized and non-hospitalized children with COVID-19. J. Allergy Clin. Immunol. Pract., 2021, 9(5), 2077-2079.e2.
[http://dx.doi.org/10.1016/j.jaip.2021.02.038] [PMID: 33676051]
[http://dx.doi.org/10.1016/j.jaip.2021.02.038] [PMID: 33676051]
[55]
DeBiasi, R.L.; Song, X.; Delaney, M. Severe coronavirus disease-2019 in children and young adults in the Washington, DC, metropolitan region. J. Pediatr., 2020, 223, 199-203.e1.
[http://dx.doi.org/10.1016/j.jpeds.2020.05.007] [PMID: 32405091]
[http://dx.doi.org/10.1016/j.jpeds.2020.05.007] [PMID: 32405091]
[56]
Beken, B.; Ozturk, G.K.; Aygun, F.D.; Aydogmus, C.; Akar, H.H. Asthma and allergic diseases are not risk factors for hospitalization in children with coronavirus disease 2019. Ann. Allergy Asthma Immunol., 2021, 126(5), 569-575.
[http://dx.doi.org/10.1016/j.anai.2021.01.018] [PMID: 33493639]
[http://dx.doi.org/10.1016/j.anai.2021.01.018] [PMID: 33493639]
[57]
Moeller, A.; Thanikkel, L.; Duijts, L. COVID-19 in children with underlying chronic respiratory diseases: survey results from 174 centres. ERJ Open Res., 2020, 6(4), 00409-02020.
[http://dx.doi.org/10.1183/23120541.00409-2020] [PMID: 33263054]
[http://dx.doi.org/10.1183/23120541.00409-2020] [PMID: 33263054]
[58]
Yang, J.M.; Koh, H.Y.; Moon, S.Y. Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study. J. Allergy Clin. Immunol., 2020, 146(4), 790-798.
[http://dx.doi.org/10.1016/j.jaci.2020.08.008] [PMID: 32810517]
[http://dx.doi.org/10.1016/j.jaci.2020.08.008] [PMID: 32810517]
[59]
Sitek, A.N.; Ade, J.M.; Chiarella, S.E. Outcomes among patients with COVID-19 and asthma: A systematic review and meta-analysis. Allergy Asthma Proc., 2021, 42(4), 267-273.
[http://dx.doi.org/10.2500/aap.2021.42.210041] [PMID: 34187619]
[http://dx.doi.org/10.2500/aap.2021.42.210041] [PMID: 34187619]
[60]
Bunyavanich, S.; Do, A.; Vicencio, A. Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. JAMA, 2020, 323(23), 2427-2429.
[http://dx.doi.org/10.1001/jama.2020.8707] [PMID: 32432657]
[http://dx.doi.org/10.1001/jama.2020.8707] [PMID: 32432657]
[61]
Shi, T.; Pan, J.; Katikireddi, S.V. Risk of COVID-19 hospital admission among children aged 5-17 years with asthma in Scotland: a national incident cohort study. Lancet Respir. Med., 2022, 10(2), 191-198.
[http://dx.doi.org/10.1016/S2213-2600(21)00491-4] [PMID: 34861180]
[http://dx.doi.org/10.1016/S2213-2600(21)00491-4] [PMID: 34861180]
[62]
Liu, S.; Zhi, Y.; Ying, S. COVID-19 and asthma: reflection during the pandemic. Clin. Rev. Allergy Immunol., 2020, 59(1), 78-88.
[http://dx.doi.org/10.1007/s12016-020-08797-3] [PMID: 32468411]
[http://dx.doi.org/10.1007/s12016-020-08797-3] [PMID: 32468411]
[63]
Carli, G.; Cecchi, L.; Stebbing, J.; Parronchi, P.; Farsi, A. Is asthma protective against COVID‐19? Allergy, 2021, 76(3), 866-868.
[http://dx.doi.org/10.1111/all.14426] [PMID: 32479648]
[http://dx.doi.org/10.1111/all.14426] [PMID: 32479648]
[64]
Johnston, S.L. Asthma and COVID-19: Is asthma a risk factor for severe outcomes? Allergy, 2020, 75(7), 1543-1545.
[http://dx.doi.org/10.1111/all.14348] [PMID: 32358994]
[http://dx.doi.org/10.1111/all.14348] [PMID: 32358994]
[65]
Konopka, K.E.; Wilson, A.; Myers, J.L. Postmortem lung findings in a patient with asthma and coronavirus disease 2019. Chest, 2020, 158(3), e99-e101.
[http://dx.doi.org/10.1016/j.chest.2020.04.032] [PMID: 32360729]
[http://dx.doi.org/10.1016/j.chest.2020.04.032] [PMID: 32360729]
[66]
Dong, X.; Cao, Y.Y.; Lu, X.X. Eleven faces of coronavirus disease 2019. Allergy, 2020, 75(7), 1699-1709.
[http://dx.doi.org/10.1111/all.14289] [PMID: 32196678]
[http://dx.doi.org/10.1111/all.14289] [PMID: 32196678]
[67]
Lippi, G.; Plebani, M.; Henry, B.M. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin. Chim. Acta, 2020, 506, 145-148.
[http://dx.doi.org/10.1016/j.cca.2020.03.022] [PMID: 32178975]
[http://dx.doi.org/10.1016/j.cca.2020.03.022] [PMID: 32178975]
[68]
Ding, B.; Lu, Y. A suggested approach for management of pediatric asthma during the COVID-19 pandemic. Front Pediatr., 2020, 8, 563093.
[http://dx.doi.org/10.3389/fped.2020.563093] [PMID: 33102407]
[http://dx.doi.org/10.3389/fped.2020.563093] [PMID: 33102407]
[69]
Heidari, S.; Mohammadi, S.; Fathi, M. Association of vitamin D status with COVID-19 disease severity in pediatric patients: A retrospective observational study. Health Sci. Rep., 2022, 5(3), e569.
[http://dx.doi.org/10.1002/hsr2.569] [PMID: 35415272]
[http://dx.doi.org/10.1002/hsr2.569] [PMID: 35415272]
[70]
Mirkarimi, M.; Alisamir, M.; Saraf, S.; Heidari, S.; Barouti, S.; Mohammadi, S. Clinical and epidemiological determinants of lower respiratory tract infections in hospitalized pediatric patients. Int. J. Pediatr., 2020, 8844420.
[http://dx.doi.org/10.1155/2020/8844420] [PMID: 33281906]
[http://dx.doi.org/10.1155/2020/8844420] [PMID: 33281906]
[71]
Mirkarimi, M.; Alisamir, M.; Nasiri, P.; Barouti, S.; Mohammadi, S. Determinants of Complicated Pneumonia in Hospitalized Pediatric Patients. Acta Med. Iran., 2021, 59(3), 155.
[http://dx.doi.org/10.18502/acta.v59i3.5786]
[http://dx.doi.org/10.18502/acta.v59i3.5786]
Related Journals
Article Metrics
1